Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis?

Area of Science:

• Neuroimmunology
• Virology
• Central Nervous System (CNS) Inflammatory Diseases

Background:

• Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
• Understanding specific antibody profiles in CNS diseases is crucial for diagnosis.
• Previous studies have explored viral associations in MS, but specific local antibody production requires further investigation.

Purpose of the Study:

• To compare specific antibody activities against various viruses in the serum and cerebrospinal fluid (CSF) of patients with MS and other inflammatory CNS diseases.
• To identify frequently produced local antibodies within the CSF compartment in MS.
• To evaluate the diagnostic significance of detecting antibodies against specific viral antigens in MS.

Main Methods:

• Quantification of specific antibody activities (antibody per weight unit IgG) in serum and CSF samples.
• Comparison of antibody profiles across patient groups, including MS, neurosyphilis, herpes simplex encephalitis, and zoster encephalitis.
• Analysis of locally produced antibodies within the CSF compartment.

Main Results:

• No non-specific antiviral activities were detected in the CSF of non-MS inflammatory diseases.
• The most frequent locally produced antibodies in MS patients were directed against measles, rubella, and zoster antigens.
• A diagnostic test targeting these three viruses showed positive results in approximately 80% of MS patients.

Conclusions:

• Local production of antibodies against measles, rubella, and zoster viruses is a common finding in multiple sclerosis.
• This specific antibody profile holds considerable diagnostic significance for MS, potentially exceeding that of the oligoclonal pattern of CSF gamma-globulins.
• Targeting these viral antigens offers a promising avenue for developing improved diagnostic tools for multiple sclerosis.